baber/WOPTO huggingface dataset:
Patent DE-60303502-D1 (DE)
Inventor: GEDON C
IPC: C07B61/00
Filed: 2003-01-17
Granted: 2006-04-20
Abstract: A process is disclosed for the synthesis of N-cycloalkylaminoalkylsilanes, wherein the process comprises hydrogenating the corresponding N-arylaminoalkylsilanes in the presence of a catalytically effective amount of a supported or unsupported catalyst selected from the group consisting of palladium, platinum, nickel, rhenium, rhodium, ruthenium, copper chromite, and mixtures of the foregoing.
Patent DE-60306913-D1 (DE)
Inventor: BIZAZZA GIUSEPPE
IPC: C03B5/027
Filed: 2003-04-08
Granted: 2006-08-31
Abstract: A method and apparatus for melting vitrifiable materials employs a melting tank for containing a molten bath with an upper surface. The tank has a floor and side walls and channels for discharging molten materials. A crown is situated above the floor and vitrifiable materials are introduced onto the upper surface of the molten bath. A plurality of electrodes having a selected shape and position are situated inside the tank for melting the vitrifiable materials with electric current. The electrodes rest on the floor and extend across the furnace to the opposite wall so as to reduce the head of the molten bath and consequently reduce melting time and energy consumption.
Patent DE-60310976-D1 (DE)
Inventor: LECLERCQ JACQUES
IPC: C03B23/035
Filed: 2003-10-08
Granted: 2007-02-15
Abstract: Fabrication of curved glass sheets involves displacing glass sheets that have been previously heated to their softening temperature and progressively conferring the desired curvature. Between the initial and final phases of bending, at a location in the line of displacement, air is continuously blown on at least one surface of the glass sheet under conditions capable of influencing in an asymmetrical fashion the final concavity of the glass sheet with respect to that which would be imparted to the final bending without the blowing of air.  Independent claims are also included for: (a) curved glass sheets obtained by this method and presenting an asymmetry able to be detected by polaroscopy or using a stratorefractometer or a biasograph; (b) a machine for the bending of glass sheets by this method.
Patent DE-60314416-D1 (DE)
Inventor: BERNING KEITH
IPC: B60S1/52
Filed: 2003-04-10
Granted: 2007-07-26
Abstract: A fluidic insert that receives fluid under pressure from a fluid inlet tube and generates a specified spatial distribution of the fluid exiting the insert includes: (1) a body member having top, bottom, front and rear outer surfaces, (2) top and bottom fluidic circuits located, respectively, at least partially within the member's top and bottom surfaces, wherein each of these circuits has at least one power nozzle, an interaction chamber, and an outlet whose exit lies within the member front surface, (3) the bottom fluidic circuit having a portion of its surface area located upstream of the power nozzle and adapted so that it can mate with a fluid inlet tube that supplies fluid to the insert, and (4) an inter-circuit flow passage that allows fluid to flow from the bottom fluid circuit to the top fluid circuit, the bottom end of this passage located such that it is downstream of the point where the inlet tube mates with the bottom circuit and upstream of the bottom circuit's power nozzle, with the top end of this passage located upstream of the top circuit's power nozzle.
Patent DE-60314658-D1 (DE)
Inventor: CLAUSEN HENRIK
IPC: A61K38/17
Filed: 2003-11-07
Granted: 2007-08-09
Abstract: Novel methods for identification of inhibitors or modulators of binding activities mediated by lectin domains of polypeptide GalNAc-transferases are disclosed. Direct binding activity of GalNAc-transferase lectins has been demonstrated for the first time and methods to measure lectin mediated binding of isolated lectins or enzymes with lectin domains are disclosed. The present invention specifically discloses a novel selective inhibitor of polypeptide GalNAc-transferase lectin domains, which provides a major advancement in that this inhibitor and related inhibitors sharing common characteristics of activity bind lectin domains without serving as acceptor substrate for glycosyltransferases involved in synthesis of O-glycans. This inhibitor is represented by the O-anomeric configuration of GalNAc-benzyl, GalNAcbeta-benzyl. Methods for inhibiting intracellular transport, cell surface expression, and secretion of mucins and O-glycosylated glycoproteins without affecting O-glycosylation processing are disclosed using the novel selective inhibitor identified.
Patent DE-60315355-D1 (DE)
Inventor: KNOX PETER
IPC: C07D487/04
Filed: 2003-12-24
Granted: 2007-09-13
Abstract: This invention relates to compounds of formula (I) and (II) that are useful in treating vascular endothelial growth factor (VEGF)-mediated disorders, particularly endometriosis and acute macular degenerative disorder. The invention also relates to a topical system for the treatment of acute macular degenerative disorder comprising a VEGF inhibitor.
Patent DE-60316156-D1 (DE)
Inventor: BELLATO ALBERTO
IPC: H04J3/16
Filed: 2003-11-17
Granted: 2007-10-18
Abstract: The present invention provides for a method and apparatus for carrying out connection and related input/output processing functions in a Sinchronous Digital Hierarchy (SDH/SONET) transport node (network), in which the payload switching matrices (e.g. MSPC and HPC matrices for an High Order VC system) collapse into one single functional block (MTRX), while the Virtual Container (VCs) monitoring functions (HVC_RX, HVC_TX) are shifted to the Input/Output position of the matrices. <IMAGE>
Patent DE-60316293-D1 (DE)
Inventor: PHILIPPE PASCAL
IPC: H03J7/02
Filed: 2003-06-23
Granted: 2007-10-25
Abstract: The invention relates to a receiver of signals [S] received from a wireless network, said receiver working at a so-called reference oscillation frequency controlled by a so-called reference value [Vref]. Said receiver includes demodulation means [DEMO] for demodulating the received signal [S], means [EST] of estimating a mean value [MV] of the demodulated signal [SD], means [COR] of correcting the mean value [MV] of the demodulated signal [SD] to the reference value [Vref], decision means [DEC] for determining the binary values adopted by the received signal [S]. According to the invention, the estimation means [EST] include first means [ESTA] of fast extraction of a first mean value [MVA] of the demodulated signal [SD] used in decision means [DEC] during a first time period and second means [ESTB] of slow extraction of a second mean value [MVB] of the demodulated signal [SD] used in correction means [COR] and, during a second time period, in decision means [DEC].
Patent DE-60321747-D1 (DE)
Inventor: WALTHER DAN E
IPC: G06F21/41
Filed: 2003-05-08
Granted: 2008-08-07
Abstract: A providing computer system may receive a request, via a stateless protocol, to access a resource. An access control application may refer to administrative rules to set validation information associated with the request. Validation information may be in the form of electronic text that is stored in a location such as a cookie or state-table. Validation information may indicate the state of a session associated with a resource, such as whether a session is in a logged-in or logged-out state. When a request is received, validation information and authentication information may be utilized together to determine if access to a resource should be granted. When access to a resource is granted or denied, validation information may be updated to indicate that the state of the session has changed.
Patent DE-60325633-D1 (DE)
Inventor: LU HARRY H
IPC: B31B50/68
Filed: 2003-11-05
Granted: 2009-02-12
Abstract: A system, and associated components and methodology, having a dunnage supply with an outlet through which one or more crumpled strips are supplied, a positioning device that positions in juxtaposition portions of the one or more strips of dunnage, and a stapler for connecting the juxtaposed portions to hold them together. In a particular system, the system includes a converter that has a conversion assembly that converts a sheet stock material into a crumpled strip of dunnage and has an outlet through which the strip of dunnage is emitted. The system also includes a coiler that rolls the strip of dunnage into a coil, and a stapler that secures the trailing end portion of the strip of dunnage to at least the next-innermost portion of the strip in the coil by inserting a staple through the trailing end portion and the juxtaposed portion of the coiled strip.
Patent DE-60327578-D1 (DE)
Inventor: MCDONALD GEORGE WALLACE
IPC: B42D15/04
Filed: 2003-02-03
Granted: 2009-06-25
Abstract: The invention provides a sheet article comprising a cover (4) comprising hingedly connected first (8) and second surfaces (6), a sheet material (12) being connected to the inside of the first surface, the second surface comprising a pocket (14), wherein the cover comprises a line of weakness (9) such that at least a portion of the first surface is removable by separation of the cover at the line of weakness, and the article comprises means for securably closing the pocket.
Patent DE-60328674-D1 (DE)
Inventor: CREA ROBERTO
IPC: C07K16/10
Filed: 2003-04-16
Granted: 2009-09-17
Abstract: Libraries of immunoglobulins of interest are described, the libraries containing mutated immunoglobulins of interest in which a single predetermined amino acid has been substituted in one or more positions in one or more complementarity-determining regions of the immunoglobulin of interest. The libraries comprise a series of subset libraries, in which the predetermined amino acid is “walked through” each of the six complementarity-determining regions (CDRs) of the immunoglobulin of interest not only individually but also for each of the possible combinatorial variations of the CDRs, resulting in subset libraries that include mutated immunoglobulins having the predetermined amino acid at one or more positions in each CDR, and collectively having the predetermined amino acid at each position in each CDR. The invention is further drawn to universal libraries containing one such library for each naturally-occurring amino acid as the single predetermined amino acid, totaling twenty libraries; and also to libraries of nucleic acids encoding the described libraries.
Patent DE-60331212-D1 (DE)
Inventor: DUBIEF CLAUDE
IPC: A61K8/41
Filed: 2003-11-05
Granted: 2010-03-25
Abstract: Production of cationic nanoemulsions comprises mixing a fatty compound (I) and a nonionic surfactant (II) in the melt, adding water to form an oil-in-water nanoemulsion, and adding a cationic surfactant. Production of cationic nanoemulsions comprises mixing a fatty compound (I) and a nonionic surfactant (II) at a temperature above the m.pt. of (I) and (II) at atmospheric pressure, where the ternary (I)/(II)/water phase diagram has at least one zone in which an oil-in-water nanoemulsion phase exists and the concentrations of (I) and (II) are selected so that this zone can be attained by simple dilution with water; adding water to form a nanoemulsion; and adding a cationic surfactant. An independent claim is also included for a cosmetic composition in the form of a cationic nanoemulsion produced as above.
Patent DE-60332213-D1 (DE)
Inventor: VAN DER GEIZE ROBERT
IPC: C12P33/00
Filed: 2003-02-19
Granted: 2010-06-02
Abstract: The invention relates to an isolated polynucleotide sequence comprising a nucleic acid sequence encoding the amino acid sequence of KshA protein or of KshB protein, encoded by nucleotides 499-1695 of SEQ ID NO:1 or by nucleotides 387-1427 of SEQ ID NO:2, respectively, and functional homologues thereof. The polynucleotides of the invention can be used to construct genetically modified microorganisms blocked in 3-ketosteroid 9alpha-hydroxylase activity, which are useful in the microbial degradation of steroids to accumulate certain steroid products.
Patent DE-60335919-D1 (DE)
Inventor: ANNUNZIATO ARMANDO
IPC: H04W16/18
Filed: 2003-08-05
Granted: 2011-03-10
Abstract: In a method of planning cellular communication networks, at least one cost function indicative of the quality of service rendered by the network is defined which takes into account the quality of service of location-based services rendered by the network. That cost function is preferably based on the concept of dilution of precision and is indicative of the quality of service of voice services, data services and location based services jointly. A system is provided for measuring at least one actual network parameter. The measurements provided by the measurement system are compared with the corresponding parameters as planned with the purpose of locating at least one critical point in the network where inadequate quality of service is being provided. Information items indicative of counter measures to be carried out in the network in order to dispense with at least one critical point are provided. The cost function may be optimised by using as input data the location of at least one base station in the cellular communication network.
Patent DE-60336602-D1 (DE)
Inventor: CHAUDHRY SAEED
IPC: A61K47/06
Filed: 2003-08-26
Granted: 2011-05-12
Abstract: Disclosed are methods of introducing a suspension or solution of a medicament, preferably mometasone furoate anhydrous, into a metered dose inhaler container, said container having a valve attached thereto, said method comprising the steps of introducing mometasone furoate anhydrous, a surfactant and a chlorflourocarbon free propellant into a vessel that is held under pressure to form a suspension or solution, circulating said suspension or solution from the vessel through a line which includes a filling head, bringing said filling head into communication with said metered dose inhaler container through said valve of said metered dose inhaler container, introducing a quantity of such suspension or solution into the container from the filling head of the line through said valve of said metered dose inhaler container, withdrawing said filling head from said metered dose inhaler container, and sealing said metered dose inhaler container, as well as the products produced thereby having an improved particle size distribution of the active ingredients in metered dose inhalers.
Patent DE-68907124-D1 (DE)
Inventor: GRANDGEORGE MICHEL
IPC: A61L2/04
Filed: 1989-04-06
Granted: 1993-07-22
Abstract: In order to stabilize solutions of human albumin for therapeutic use for the purpose of their treatment by heat in a container, in particular in the final container, there is added, in addition to the usual stabilizing formula, a surfactant agent selected from among Tween 80, Tween 20, Pluronic F68, laurate of polyethylene glycol 600 or any other equivalent agent.
Patent DE-68909448-D1 (DE)
Inventor: HANSEN KRISTIAN TAGE
IPC: C07D403/14
Filed: 1989-02-28
Granted: 1993-11-04
Abstract: Compounds having the formula <CHEM>  wherein R<1> is H, halogen, or C1-4 alkyl  R<2> is halogen, CF3, CN  R<4> is H, or halogen R<5> is furyl, thienyl, pyridyl, or ring systems consisting of phenyl ortho condensed with a benzen, cyclohexan, cyclohexen, cyclopentan or cyclopenten ring in which rings one of the carbon atoms may be exchanged with oxygen, sulphur or nitrogen, and each of these ring systems optionally are substituted with halogen, hydroxy or alkoxy with or not more than 4 carbon atoms,  R<6> is H or CH3  R<7> is H or C1-4 alkyl  R<8> is H, alkyl, aralkyl, cycloalkyl, or aryl R<9> is H, or R<9> together with R<8> form a piperidino, pyrrolidinyl, morpholino, or piperazinyl ring or a ring with the formula  or R<9> can be alkyl or alkoxycarbonyl with the formula    CHR<1><1> - @ - OR<1><3>  where R<1><1> is H, CH3, (CH3)2CH, CH2CH(CH3)2, <CHEM> and R<1><3> is H, alkyl, cycloalkyl, aralkyl, or a 2-acetamide group with the formula <CHEM>  where R<1><5> is H, CH3, C2H5, C3H8, or CH(CH3)2, and  R<1><4> is H, CH3, C2H5, C3H8 or CH(CH3)2 ,  and pharmaceutical-acceptable salts thereof. The compounds are useful as prodrugs for compounds active for the treatment of mental disorders.
Patent DE-68914628-D1 (DE)
Inventor: DUBEY CONRAD
IPC: G09F11/00
Filed: 1989-12-11
Granted: 1994-05-19
Abstract: The postcard comprises a main image which may be of the usual format, and one or more secondary images such as illustrations or printed messages supplementary to the main image. The card comprises an outer envelope (1) in the form of a wallet, bearing the main image (20) on the recto and possibly areas for the address and correspondence on the verso. An inner sheet (9) may, for example, slide into this envelope, and bears at least two sets of secondary images (23 to 28) appearing in windows (21) in the envelope. One of these sets may display the portions of the main image (20) which are occupied by the windows, so that this image is complete when the inner sheet (9) is inserted. Other embodiments may have pivoting internal elements, which are rotated by a direct movement or by means of a sliding tag. <IMAGE>
Patent DE-68915209-D1 (DE)
Inventor: HUIZINGA TOM
IPC: C10G49/08
Filed: 1989-06-19
Granted: 1994-06-16
Abstract: Process for the preparation of a zeolitic catalyst which comprises treating a zeolite of the Y-type having an alkali metal oxide/aluminium oxide molar ratio of at most 0.13 with a solution of a multi-valent metal salt having a cationic radius between 0.6 and 1.0  ANGSTROM  and combining the ion-exchanged zeolite without a calcination step with a hydrogenation component of a Group 8 and/or Group 6b metal.
Patent DE-68918398-D1 (DE)
Inventor: HUSTAD GERALD ORTON
IPC: B65D43/04
Filed: 1989-11-02
Granted: 1994-10-27
Abstract: This invention pertains to a method of forming a reclosable package having a body member (18), a base (12), a hermetic seal between the body member (18) and base (12) and snap locking projections (24) in the side walls of the body member (18) and base (12). <IMAGE>
Patent DE-68921671-D1 (DE)
Inventor: MINCHIN MICHAEL CHRISTOPHER WA
IPC: C07C255/24
Filed: 1989-06-02
Granted: 1995-04-20
Abstract: The invention concerns a method for treating depression or senile dementia using a compound which acts selectively as an agonist of gamma aminobutyric acid (GABA) at GABA autoreceptors with the proviso that the compound is not fengabine and progabide.
Patent DE-68922623-D1 (DE)
Inventor: DAEMS DANIEL
IPC: G02B6/24
Filed: 1989-11-07
Granted: 1995-06-14
Abstract: PCT No. PCT/GB89/01326 Sec. 371 Date May 7, 1991 Sec. 102(e) Date May 7, 1991 PCT Filed Nov. 7, 1989 PCT Pub. No. WO90/05318 PCT Pub. Date May 17, 1990.An enclosure capable of enclosing a butt splice between at least two optical fibre cables, which comprises: a base through which respective cables can pass; at least one optical fire organizer capable of storing an optical fibre in the path from one of the outlets to another of the outlets, said path having a minimum radius of curvature no smaller than the minimum bend radius of said optical fibre; and a hollow cover which can surround the organizer and which can be fixed to the base to close the enclosure; the base being removable from the splice by sliding over the organizer.
Patent DE-68928319-D1 (DE)
Inventor: TANIGUCHI YASUSHI
IPC: H05B33/18
Filed: 1989-12-27
Granted: 1997-10-16
Abstract: An electric field effect light emitting device comprises a light emitting layer consisting of a diamond-like carbon film containing oxygen. <IMAGE>
Patent DE-69009469-D1 (DE)
Inventor: PITT ALAN
IPC: C09K23/00
Filed: 1990-04-13
Granted: 1994-07-07
Abstract: Water-soluble, non-ionic surface active compounds are provided having the formula   <IMAGE>   wherein R1 and R2 are each independently hydrogen or an alkyl group having from 1 to 4 carbon atoms; X is a hydrophobic substituted or unsubstituted arylene group or a hydrophobic substituted or unsubstituted alkylene group; Y1 and Y2 are each independently a chemical bond, -CO- or -(CH2)mNR3CO-; m is an integer from 1 to 6; R3 is as defined for R1 and R2; and, Z1 and Z2 are each independently a hydrophilic polyhydroxyalkyl group. The compounds are particularly useful as coating aids for the coating of hydrophilic colloid layers in the preparation of photographic materials.
Patent DE-69017252-D1 (DE)
Inventor: NAKAMURA FUMIHARU
IPC: B41J2/165
Filed: 1990-04-25
Granted: 1995-04-06
Abstract: An ink jet recording apparatus has an ink jet head (7) provided with a discharge port forming surface (8) formed with discharge ports for discharging ink therethrough, a cleaning member (1) for bearing against the discharge port forming surface (8) of the ink jet head (7) to clean the discharge port forming surface (8), recording mode setting means capable of setting a first recording mode in which the ink is discharged from the ink jet head (7) to effect recording, and a second recording mode differing from the first recording mode, cleaning mode setting means capable of setting a first cleaning mode corresponding to the first recording mode set by the recording mode setting means, and a second cleaning mode corresponding to the second recording mode set by the recording mode setting means, and driving means for moving the ink jet head (7) and the cleaning member (1) relative to each other to effect the cleaning of the discharge port forming surface (8).
Patent DE-69018650-D1 (DE)
Inventor: ASMUS ROBERT
IPC: C09J183/00
Filed: 1990-12-13
Granted: 1995-05-18
Abstract: A composite of a gel of swollen hydrocolloid dispersed in a pressure sensitive adhesive matrix is provided. The gel has a natural or synthetically derived hydrocolloid swollen with a non-volatile swelling agent, such that the gel may have a shear modulus of less than 6.2 x 10<6> dynes/cm<2>. The gel-adhesive composite has continued skin adhesion whether applied to or existing in dry or moist skin conditions. The gel contributes a high moisture vapor transmission rate to attempt to maintain dry skin conditions while the adhesive maintains skin adhesion. The gel-adhesive composite may be used in a variety of tape, dressing, bandage, drape, or other skin contacting usage and may optionally include antimicrobial agents to treat the skin while adhesion continues.
Patent DE-69023882-D1 (DE)
Inventor: ALBERTONI MARTINO
IPC: H01H50/46
Filed: 1990-08-21
Granted: 1996-01-11
Abstract: The miniaturized power relay for printed circuits comprises an electromagnetic circuit (2) complete with coil (39), a contact-holder block (3) provided with an actuator (25) and a protection and sealing covering (4); the magnetic circuit has exclusively a fixed supporting element (5) and a movable keeper element (6) the respective polar expansions whereof (7, 8) are conveniently shaped so as to reduce dimensions and are accommodated inside the coil to use all of the magnetic flux which is generated by the coil itself.
Patent DE-69033806-D1 (DE)
Inventor: BASTIOLI CATIA
IPC: B29C48/08
Filed: 1990-05-28
Granted: 2001-10-25
Abstract: Biodegradable composition comprising destructured starch, a thermoplastic polymer and a high-boiling plasticiser in an amount from 0.05 to 100% of the weight of the starch, where in the starch is obtained by destructuring starch as it is without the addition of water.
Patent DE-69108138-D1 (DE)
Inventor: TAKATANI MUNEO
IPC: C07D471/04
Filed: 1991-07-30
Granted: 1995-04-20
Abstract: A calmodulin inhibitory composition containing a compound of the formula (I): <CHEM> as well as an angiogenesis inhibitory composition containing a compound of the formula (1): <CHEM> are disclosed. c
Patent DE-69113790-D1 (DE)
Inventor: BADERTSCHER ERNEST
IPC: A23P30/40
Filed: 1991-06-14
Granted: 1995-11-16
Abstract: Expanded foodstuff comprising a fat and a matured (refined) mixture, and method for its preparation by means of maturing (refining) and expansion.
Patent DE-69114917-D1 (DE)
Inventor: NACCI GAETANO
IPC: A61M5/32
Filed: 1991-01-04
Granted: 1996-01-11
Abstract: PCT No. PCT/EP91/00005 Sec. 371 Date Sep. 6, 1991 Sec. 102(e) Date Sep. 6, 1991 PCT Filed Jan. 4, 1991 PCT Pub. No. WO91/10461 PCT Pub. Date Jul. 25, 1991.A syringe is provided with an engagement device which at the end of the plunger travel becomes connected to the hypodermic needle and to a pneumatic actuator, preferably of vacuum type, arranged to cause the needle to enter an appropriate chamber in the plunger after use.